"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments and email. This allows you to still get great care while helping to address the community spread of COVID-19. To book an in-person appointment, or if you’re concerned about your specific health condition, visit our website for your local information on appointments and 24/7 advice."

During the past decade, Kaiser Permanente - San Jose conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 16 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 12 clinical trials were completed. i.e. 240% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente - San Jose" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Pfizer" with 4 trials sponsored, "Genentech, Inc." with 3 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Telik" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente - San Jose" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Seagen Inc." with 2 trials as a collaborator and "Albany Stratton VA Medical Center" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente - San Jose" are "Breast Cancer" (5 trials), "COVID-19" (2 trials), "Advanced Solid Tumors" (1 trials), "Advanced Unresectable or Metastatic Solid Malignancy" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Kaiser Permanente - San Jose" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente - San Jose" are "Drug" (21 trials), "Biological" (4 trials), "Behavioral" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Paclitaxel" (5 trials), "Docetaxel" (4 trials), "Trastuzumab" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente - San Jose" are 24 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente - San Jose". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Kaiser Permanente - San Jose, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente - San Jose, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".